Results 101 to 110 of about 4,973 (174)

Distinguishing self from non-self RNA by editing-specific inosine patterns. [PDF]

Nucleic Acids Res
Varada R, Leuchtenberger AF, Vesely C, Kaczmarek B, Mansouri Khosravi H, Mandl TC, Milanovic K, Honarmand Tamizkar K, Rajendra V, Senoner H, Steinbichl L, Borojevic M, Sombke A, Schmidt K, Eckhard M, Hofacker IL, Walkley C, Heraud-Farlow JE, Picardi E, Bernecky C, Jantsch MF.   +20 more
europepmc   +1 more source

Z-nucleic acid-mediated PANoptosis in infection, inflammation, and cancer. [PDF]

Commun Biol
Thapa N, Kim A, Patel P, Nguyen MQ, Lee E, Karki R.   +5 more
europepmc   +1 more source

Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance. [PDF]

iScience
Ai ZE, Bian Y, Li G, Wang XS, Zhu S, Li Y, Yao X, Yan Z.   +7 more
europepmc   +1 more source

ADAR1-circRAB5A-BIP axis governs radiotherapy resistance in colorectal cancer through coordinating protective autophagy and apoptosis. [PDF]

Cancer Biol Ther
Chen W, Zhang X, Zhao Z, Xin W, Li J, Che X.   +5 more
europepmc   +1 more source

Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12. [PDF]

Nat Commun
Xia Q, Pan J, Weng X, Li S, Li J, Song S, Li J, Zhou B, Liu X, Kuang DM, Zhang N, Jin J, Liu J, Lin Z, Yu S, Tang Q, Bian L, Zeng Y, Shi Y, Zheng Y, Liao JY, Xu S, Su S.   +22 more
europepmc   +1 more source

Orchestrating innate immunity through RNA editing and helicase activity: ADAR1, dsRNA sensors, and tumor immune evasion. [PDF]

Front Cell Dev Biol
Minakuchi M, Salvino JM, Villanueva J.
europepmc   +1 more source

SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19. [PDF]

Int J Mol Sci
Mukundan Nair A, Piontkivska H.
europepmc   +1 more source

Immune response to DNA and RNA: structural insights, molecular mechanisms, and therapeutic targeting. [PDF]

Mol Biomed
Xia L, Wang Y, Yan X, Zhang H.
europepmc   +1 more source

Engineering editopes through programmable RNA editing toward tumor neoantigen generation. [PDF]

EMBO J
Pecori R, Casati B, Merdler-Rabinowicz R, Landesman N, Sanghvi K, Zens S, Bilgin E, Topouzi M, Kipfstuhl K, Pinamonti V, Arnold A, Abukhalaf M, Gomez-Zepeda D, Tenzer S, Lindner JM, Platten M, Offringa R, Carretero R, Ruppin E, Levanon EY, Papavasiliou FN.   +20 more
europepmc   +1 more source

ADAR1 Regulates Alternative Splicing Through an RNA Editing-Independent Mechanism. [PDF]

Int J Mol Sci
Sagredo EA, Karlström V, Blanco A, Moraga P, Vergara M, Jarvelin AI, Visa N, Marcelain K, Castello A, Armisén R.   +9 more
europepmc   +1 more source